Neurocrine Biosciences (NBIX) Insider Trading & Ownership $125.69 +0.27 (+0.22%) As of 06/30/2025 04:00 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Neurocrine Biosciences (NASDAQ:NBIX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage4.30%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)8Amount OfInsider Selling(Last 12 Months)$49.49M Get NBIX Insider Trade Alerts Want to know when executives and insiders are buying or selling Neurocrine Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address NBIX Insider Buying and Selling by Quarter Neurocrine Biosciences Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails5/27/2025Kevin Charles GormanDirectorSell9,613$120.38$1,157,212.94 5/5/2025William H RastetterDirectorSell30,000$110.20$3,306,000.00 2/13/2025Julie CookeInsiderSell1,551$116.78$181,125.78 2/13/2025Kevin Charles GormanDirectorSell5,844$116.69$681,936.36 2/13/2025Matt AbernethyCFOSell2,558$116.86$298,927.88 2/10/2025Julie CookeInsiderSell700$118.28$82,796.00 2/10/2025Kevin Charles GormanDirectorSell2,274$118.37$269,173.38 2/10/2025Kyle GanoCEOSell980$118.39$116,022.20 2/3/2025Ingrid DelaetInsiderSell623$149.29$93,007.67 1/31/2025Julie CookeInsiderSell1,740$152.89$266,028.60 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 1/31/2025Kevin Charles GormanDirectorSell2,707$152.92$413,954.44 1/31/2025Kyle GanoCEOSell1,541$152.87$235,572.67 1/31/2025Matt AbernethyCFOSell1,283$152.87$196,132.21 1/27/2025Kevin Charles GormanDirectorSell146,105$149.46$21,836,853.30 1/15/2025Kyle GanoCEOSell65,000$141.50$9,197,500.00 12/31/2024Ingrid DelaetInsiderSell272$138.10$37,563.20 12/17/2024Ingrid DelaetInsiderSell1,091$135.00$147,285.00 11/29/2024Jude OnyiaInsiderSell2,331$126.29$294,381.99 8/15/2024William H RastetterDirectorSell14,250$146.69$2,090,332.50 8/13/2024Gary A LyonsDirectorSell11,570$150.43$1,740,475.10 8/13/2024Ingrid DelaetInsiderSell7,143$150.10$1,072,164.30 8/13/2024Matt AbernethyCFOSell14,100$150.38$2,120,358.00 8/6/2024Ingrid DelaetInsiderSell273$147.70$40,322.10 8/1/2024Julie CookeInsiderSell12,632$153.26$1,935,980.32 7/16/2024Gary A LyonsDirectorSell930$150.03$139,527.90 7/16/2024Julie CookeInsiderSell900$150.04$135,036.00 7/1/2024Julie CookeInsiderSell10,000$140.19$1,401,900.00 (Data available from 1/1/2013 forward) NBIX Insider Trading Activity - Frequently Asked Questions Who is on Neurocrine Biosciences' Insider Roster? The list of insiders at Neurocrine Biosciences includes Darin Lippoldt, David W Boyer, Eiry Roberts, Eric Benevich, Gary A Lyons, George J. Morrow, Ingrid Delaet, Jude Onyia, Julie Cooke, Kevin Charles Gorman, Kyle Gano, Leslie V. Norwalk, Malcolm Lloyd-Smith, Matt Abernethy, Neurocrine Biosciences Inc, Richard F Pops, Shalini Sharp, Stephen A Sherwin, and William H Rastetter. Learn more on insiders at NBIX. What percentage of Neurocrine Biosciences stock is owned by insiders? 4.30% of Neurocrine Biosciences stock is owned by insiders. Learn more on NBIX's insider holdings. Which Neurocrine Biosciences insiders have been selling company stock? The following insiders have sold NBIX shares in the last 24 months: Darin Lippoldt ($5,121,159.93), David W Boyer ($700,550.20), Eiry Roberts ($3,331,855.97), Eric Benevich ($13,096,428.48), Gary A Lyons ($5,284,628.00), George J. Morrow ($5,576,800.00), Ingrid Delaet ($2,624,921.77), Jude Onyia ($902,482.92), Julie Cooke ($4,094,273.02), Kevin Charles Gorman ($40,872,589.79), Kyle Gano ($19,409,344.87), Leslie V. Norwalk ($1,085,360.00), Matt Abernethy ($5,621,659.53), Richard F Pops ($2,239,135.00), Shalini Sharp ($156,941.40), Stephen A Sherwin ($5,338,400.00), and William H Rastetter ($6,848,287.18). How much insider selling is happening at Neurocrine Biosciences? Insiders have sold a total of 900,151 Neurocrine Biosciences shares in the last 24 months for a total of $122,304,818.06 sold. More Insider Trading Tools from MarketBeat Related Companies Alnylam Pharmaceuticals Insider Buying Biogen Insider Buying Incyte Insider Buying United Therapeutics Insider Buying Exelixis Insider Buying BioMarin Pharmaceutical Insider Buying Exact Sciences Insider Buying Repligen Insider Buying Halozyme Therapeutics Insider Buying Madrigal Pharmaceuticals Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles The Top Insider Sells From Q2: Buy, Sell, or Hold?3 Hot Trades for Insiders, But Are They Good Buys for Investors?Insiders Chase Income and Stability in American Tower—Here’s Why3 Tech Stocks With High and Rising Institutional Interest3 Summer Stocks With Insider Buying and Analyst Support This page (NASDAQ:NBIX) was last updated on 7/1/2025 by MarketBeat.com Staff From Our PartnersHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | SponsoredNvidia’s Huang: AI is going to need 100x more power12Nvidia CEO Jensen Huang didn't mince words. After Nvidia's latest earnings call, Huang said AI now requires...Weiss Ratings | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredTrump Makes Major Crypto AnnouncementTrumps “Secret Weapon” for Crypto Dominance There's a growing push for America to lead the next wave of dig...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neurocrine Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Neurocrine Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
